Emission computed tomography vs perfusion scanning in lung disease
β Scribed by J. J. Jeune; J. Maublant; M. Lahellec; A. Veyre
- Publisher
- Springer
- Year
- 1982
- Tongue
- English
- Weight
- 229 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
β¦ Synopsis
Emission computed tomography has achieved considerable credibility in thallium-201 cardiac imaging and in brain imaging studies. To date the procedure has had only limited application in the study of other organs. In the present study traditional perfusion lung scans were compared with horizontal, sagittal and frontal tomograms in 30 patients. Preliminary results showed agreement between the two methods in most cases. Tomography, however, gave more precise information about the site and extent of areas of deficient lung perfusion. In a small number of cases tomography also revealed defect not seen on conventional scans. In patients with cardiomegaly in whom conventional scanning data were difficult to assess, tomography proved enlightening.
π SIMILAR VOLUMES
Single photon emission computed tomography (SPECT) using perfusion tracers makes it possible to estimate regional cerebral blood flow (rCBF) and, indirectly, local brain metabolism. It may be possible to detect and follow physiopathological alterations, such as may be seen in seizure disorders. The
Twenty patients with known metastatic cancer or high-risk primary cancer developed new lesions on Tc 99m bone scans and had normal plain radiographs. Spinal computed tomography (CT) was performed on all new bone-scan-positive lesions in minimal examination time. Fifteen patients had extensive metast
## Abstract Computed tomography (CT) is the current βgold standardβ for assessment of lung morphology and is so far the most reliable imaging modality for monitoring cystic fibrosis (CF) lung disease. CT has a much higher radiation exposure than chest xβray. The cumulative radiation dose for lifeβl
Single photon emission computed tomography with [123 I] isopropylamphetamine was carried out on a patient with motor neuron disease with dementia. [123 I] uptake was decreased in the frontal lobes. This would reflect the histopathological findings such as neuronal loss and gliosis in the frontal lob